Memel Biotech UAB is a Lithuanian CDMO providing GMP manufacturing services for Advanced Therapy Medicinal Products (ATMPs) for the clinical research community. Launched by the Cureline Group in 2024, Memel Biotech offers ATMP development and manufacturing services from facilities in Lithuania (Klaipeda and Vilnius). The company collaborates with Therabest on exosome-based cell therapies. Memel Biotech focuses on cell and gene therapy manufacturing at clinical scale, positioning itself as a new CDMO in the Baltics for the ATMP sector.
ATMP manufacturing, cell therapy GMP production, exosome-based therapies, clinical-stage manufacturing
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.